Pediatrix Medical Group, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $39.8M | $29.6M | $33.7M | $71.7M | $39.3M | $20.7M | $30.5M | $19.4M |
| Depreciation & Amortization | $5.8M | $6.1M | $5.6M | $5.6M | $5.3M | $5.3M | $6.9M | $6.3M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $5.1M | $4.7M | $5.3M | $5.2M | $3.9M | $3.6M | $2.7M | $4.1M |
| Net Cash from Operating Activities | $125.3M | $-129.8M | $114.1M | $137.3M | $137.2M | $-117.5M | $133.0M | $91.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.4M | $6.2M | $5.3M | $5.3M | $4.5M | $3.3M | $3.4M | $6.3M |
| Business Acquisitions | $0 | $7.0M | $4.0M | $19.2M | $0 | $0 | $0 | $0 |
| Net Cash from Investing Activities | $6.0M | $-12.0M | $-10.3M | $6.6M | $-7.2M | $-7.5M | $-1.9M | $-4.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $42.7M | $21.5M | $64.0M | $20.9M | $209.0K | $1.6M | $643.0K | $162.0K |
| Net Cash from Financing Activities | $-48.2M | $-27.6M | $-68.6M | $-28.6M | $-4.3M | $-6.0M | $-5.0M | $-3.1M |
| Net Change in Cash | $83.1M | $-169.5M | $35.2M | $115.3M | $125.8M | $-131.0M | $126.1M | $84.4M |
| Free Cash Flow | $123.9M | $-136.1M | $108.8M | $131.9M | $132.7M | $-120.8M | $129.6M | $85.5M |